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Using samples from the
Resistant-Bacteria Bank,
industry and academic
institutions will team
up with CDC to help
patients, like George,
receive earlier diagnosis
and effective treatment. 
Detect and Protect
Against Antibiotic
Resistance 
CDC’s Initiative will speed up antibiotic 
resistance detection and production
of new antibiotics and diagnostics 
While in the hospital for surgery, 
George develops a bloodstream 
infection and the first round of 
antibiotics aren’t 
working. 
The hospital lab results show George’s
blood has Carbapenem-resistant
Enterobacteriaceae (CRE), known as
“nightmare bacteria,”
which has become resistant to all
or nearly all available antibiotics. 
CRE samples from George’s blood
will be sent to a lab in the
Antimicrobial Resistance (AR)
Lab Network for confirmation
and characterization. 
CDC will work with the 
AR Regional Lab Network 
to send samples and data to a 
Resistant-Bacteria 
Bank.Pharmaceuticalcompanies will use samples 
to test new antibiotic agents. 
Biotech and diagnostic 
companies will use samples to design 
next-generation clinical tests. 
Researchers will use samples
to study emerging resistance 
and investigate spread 
of AR pathogens. 
CDC and 5 Regional Labs 
Equipped with CDC’s gold-standard
capacity to identify any type of
resistance, members of the
Antimicrobial Resistance
Regional Lab Network
will serve as a national resource
to support hospital labs. 
The regional labs will have
cutting-edge technology
that can provide more
information on where
detected resistance came
from and how it is related
to other types of resistance
across the country. 
Through the regional lab
network, CDC and public
health will be able to
accumulate real-time,
actionable information
about dangerous antibiotic
resistant threats. 
Hospital labs
have the ability to
identify most but
not all types of
antibiotic resistance,
especially novel
forms of resistance. 
From this bank,
samples will be
available to industry
and academics for
diagnostic and
drug development. 
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